Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome

CHEMERIN IS AN INDEPENDENT MARKER OF THE METABOLIC SYNDROME IN A CAUCASIAN POPULATION - A PILOT STUDY

(2012) David Stejskal et al.   BIOMEDICAL PAPERS-OLOMOUC

Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease

(2010) Karin Müller et al.   ATHEROSCLEROSIS

Circulating Levels of the Adipokine Chemerin in Gestational Diabetes Mellitus

(2010) Dörte Pfau et al.   Hormone Research in Paediatrics

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes

(2009) Johanna Weigert et al.   CLINICAL ENDOCRINOLOGY

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

(2009) Michael Lehrke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population

(2009) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Emerging inflammatory markers for assessing coronary heart disease risk

(2009) Marshall A. Corson   Current Cardiology Reports

Metabolic Syndrome Predicts 10-Year Mortality in Non-Diabetic Patients Following Coronary Artery Bypass Surgery

(2008) Kan Kajimoto et al.   CIRCULATION JOURNAL

Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronary-angiographic alterations

(2008) Bela C. Solymoss et al.   CORONARY ARTERY DISEASE